Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Natural Resources
CNQ
|
+$1.58B |
| 2 |
iShares MBS ETF
MBB
|
+$1.49B |
| 3 |
RTX Corp
RTX
|
+$839M |
| 4 |
Microsoft
MSFT
|
+$566M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$555M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$1.27B |
| 2 |
Advanced Micro Devices
AMD
|
+$920M |
| 3 |
iShares Expanded Tech-Software Sector ETF
IGV
|
+$682M |
| 4 |
VanEck Semiconductor ETF
SMH
|
+$567M |
| 5 |
Vanguard Information Technology ETF
VGT
|
+$291M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.6% |
| 2 | Financials | 11.61% |
| 3 | Healthcare | 9.91% |
| 4 | Consumer Discretionary | 9.26% |
| 5 | Industrials | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
First Industrial Realty Trust
FR
$8.44B
| $5.91M | ﹤0.01% |
124,482
-479
| -0.4% | -$22.9K |
|
|
ANSS
477
DELISTED
Ansys
ANSS
| $5.86M | ﹤0.01% |
18,242
+284
| +2% | +$93.1K |
|
478
Alkermes
ALKS
$8.22B
| $5.85M | ﹤0.01% |
242,638
+29,201
| +14% | +$716K |
|
479
Federal Realty Investment Trust
FRT
$10.4B
| $5.67M | ﹤0.01% |
56,108
+35
| +0.1% | +$3.53K |
|
480
F5
FFIV
$23.1B
| $5.5M | ﹤0.01% |
31,938
+1,801
| +6% | +$315K |
|
|
INVX
481
Innovex International
INVX
$1.99B
| $5.31M | ﹤0.01% |
285,409
-7,855
| -3% | -$152K |
|
482
Hexcel
HXL
$7.76B
| $5.3M | ﹤0.01% |
84,815
+6,373
| +8% | +$427K |
|
483
Cooper Companies
COO
$14.4B
| $5.28M | ﹤0.01% |
60,534
+4,477
| +8% | +$418K |
|
484
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
| $5.25M | ﹤0.01% |
102,328
+9,783
| +11% | +$498K |
|
485
Vanguard Morningstar Growth ETF
VUG
$231B
| $5.2M | ﹤0.01% |
83,370
-109,428
| -57% | -$6.38M |
|
486
Viridian Therapeutics
VRDN
$2.6B
| $5.15M | ﹤0.01% |
395,497
+6,410
| +2% | +$88.7K |
|
487
Advanced Drainage Systems
WMS
$11.3B
| $5.11M | ﹤0.01% |
31,876
-1,526
| -5% | -$255K |
|
488
Silicon Laboratories
SLAB
$7.24B
| $5.1M | ﹤0.01% |
46,074
+3,385
| +8% | +$418K |
|
489
NNN REIT
NNN
$8.99B
| $5.08M | ﹤0.01% |
119,203
+15
| +0% | +$624 |
|
490
Broadstone Net Lease
BNL
$3.96B
| $5.05M | ﹤0.01% |
318,032
| – | – |
|
491
Donnelley Financial Solutions
DFIN
$1.17B
| $4.99M | ﹤0.01% |
83,761
-15,665
| -16% | -$956K |
|
492
Global Payments
GPN
$22.7B
| $4.85M | ﹤0.01% |
50,120
-20,939
| -29% | -$2.31M |
|
493
ResMed
RMD
$30.3B
| $4.82M | ﹤0.01% |
25,164
+897
| +4% | +$182K |
|
|
SAGE
494
DELISTED
Sage Therapeutics
SAGE
| $4.74M | ﹤0.01% |
436,421
+3,952
| +0.9% | +$50.6K |
|
495
Globant
GLOB
$1.59B
| $4.68M | ﹤0.01% |
26,248
-288
| -1% | -$50.8K |
|
496
MYR Group
MYRG
$5.26B
| $4.61M | ﹤0.01% |
33,993
+21,426
| +170% | +$3.35M |
|
497
Ligand Pharmaceuticals
LGND
$5.84B
| $4.47M | ﹤0.01% |
53,019
-358
| -0.7% | -$28.5K |
|
498
Celldex Therapeutics
CLDX
$3.3B
| $4.46M | ﹤0.01% |
120,544
-3,292
| -3% | -$124K |
|
499
Campbell Soup
CPB
$6.81B
| $4.46M | ﹤0.01% |
98,632
+9,202
| +10% | +$410K |
|
500
FormFactor
FORM
$9.29B
| $4.42M | ﹤0.01% |
72,947
-11,643
| -14% | -$607K |
|
Similar funds
Ken Fisher's Q2 2024 Portfolio in Review
As of Q2 2024, Ken Fisher held 1,069 positions worth $230B, up 7.4% from $214B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Ken Fisher deployed $7.03B of net new capital in Q2 2024, opening 105 new positions and adding to 492 existing holdings. Its largest new stake was ZTO Express: 3,166,868 shares worth $65.7M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR Portfolio Short Term Treasury ETF, an estimated $1.27B trimmed.
- Ken Fisher's largest Q2 2024 buy was ZTO Express: 3,166,868 shares worth $65.7M.
- Ken Fisher added most to Canadian Natural Resources in Q2 2024, an estimated $1.58B increase.
- Ken Fisher's biggest Q2 2024 reduction was State Street SPDR Portfolio Short Term Treasury ETF, cutting an estimated $1.27B.
- Ken Fisher fully exited Thor Industries in Q2 2024, selling an estimated $24.5M.
- Ken Fisher's ten largest holdings make up 34% of its $230B portfolio in Q2 2024.
- Ken Fisher opened 105 new positions and closed 83 in Q2 2024.
- Ken Fisher's portfolio value rose 7.4% quarter-over-quarter to $230B.
Based on Fisher Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.